COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1114: Articles 11131-11140  | Next

SARS-CoV-2 Delta variant saliva viral load is 15-fold higher than wild-type strains
Imai, K., Ikeno, R., Tanaka, H., Takada, N.
10.1101/2021.11.29.21266980 — Posted: 2021-11-30
Phase Shift Between Age-Specific COVID-19 Incidence Curves Points to a Potential Epidemic Driver Function of Kids and Juveniles in Germany
Diebner, H. H.
10.1101/2021.11.29.21267004 — Posted: 2021-11-30
Normalisation of SARS-CoV-2 concentrations in wastewater: the use of flow, conductivity and CrAssphages
Langeveld, J., Schilperoort, R., Heijnen, L., elsinga, g., schapendonk, c., fanoy, e., de schepper, e., Koopmans, M., de Graaf, M., Medema, G.
10.1101/2021.11.30.21266889 — Posted: 2021-11-30
SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens
Bartolo, L., Afroz, S., Pan, Y.-G., Xu, R., Williams, L., Lin, C.-F., Friedman, E. S., Gimotty, P. A., Wu, G. D., Su, L.
10.1101/2021.11.29.470421 — Posted: 2021-11-30
Use of heat-not-burn tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers
Yamamoto, S., Tanaka, A., Ohmagari, N., Yamaguchi, K., Ishitsuka, K., Morisaki, N., Kojima, M., Nishikimi, A., Tokuda, H., Inoue, M., Tanaka, S., Umezawa, J., Okubo, R., Nishimura, K., Konishi, M., Miyo, K., Mizoue, T.
10.1101/2021.11.29.21267032 — Posted: 2021-11-30
Th1, Th2 and Th17 inflammatory pathways synergistically correlate with cardiometabolic processes. A case study in COVID-19.
Michels, J. R., Nazrul, M. S., Adhikari, S., Wilkins, D., Pavel, A. B.
10.1101/2021.11.29.470414 — Posted: 2021-11-30
SARS-CoV-2 Virus like Particles produced by a single recombinant baculovirus generate potent neutralizing antibody that protects against variant challenge
Sullivan, E., Sung, P.-y., Wu, W., Berry, N., Kempster, S., Ferguson, D., Almond, N., Jones, I. M., Roy, P.
10.1101/2021.11.29.470349 — Posted: 2021-11-30
Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta Spike as well as Nucleocapsid Antigens
Rice, A., Verma, M., Voigt, E., Battisti, P., Beaver, S., Reed, S., Dinkins, K., Mody, S., Zakin, L., Sieling, P., Tanaka, S., Morimoto, B., Higashide, W., Olson, C. A., Gabitzsch, E. R., Safrit, J. T., Spilman, P. R., Casper, C., Soon-Shiong, P.
10.1101/2021.11.29.470440 — Posted: 2021-11-30
A human monoclonal antibody potently pan-neutralizes SARS-CoV-2 VOCs by targeting RBD invariant sites
Wang, X., Hu, A., Chen, X., Zhang, Y., Yu, F., Yue, S., Li, A., Zhang, J., Pan, Z., Yang, Y., Lin, Y., Gao, L., Zhou, J., Zhao, J., Li, F., Shi, Y., Huang, F., Yang, X., Peng, Y., Tu, L., Zhang, H., Zheng, H., He, J., Zhang, H., Xu, L., Huang, Q., Zhu, Y., Deng, K., Ye, L.
10.1101/2021.11.29.470356 — Posted: 2021-11-30
Peptide-antibody Fusions Engineered by Phage Display Exhibit Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants
Labriola, J. M., Miersch, S., Chen, G., Chen, C., Pavlenco, A., Pisanu, F., Caccuri, F., Zani, A., Sharma, N., Feng, A., Leung, D. W., Caruso, A., Amarasinghe, G. K., Sidhu, S.
10.1101/2021.11.29.470362 — Posted: 2021-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).